Lactose (India) Limited (LACTOSE.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹101.00 (-0.59%) as of
Key statistics
- Market cap
- 1.27B
- P/E (TTM)
- 18.67
- EPS (TTM)
- 5.41
- Dividend yield
- 0.00%
- 52-week range
- 76.01 – 136.45
- Beta
- 0.75
- Revenue (TTM)
- 1.71B
- Profit margin
- 4.06%
- Volume
- 1.01k
About Lactose (India) Limited
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; liquid dosage forms; and anhydrous and inhalation grade lactose. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.